Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheelu Varghese

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry|January 21, 2023
Development of fluorophore labeled or biotinylated anticancer small molecule NSC243928Rahul Prakash, Dustin W Goodlett, Sheelu Varghese, et al.
Cancer Letters|February 22, 2023
Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interactionBenson Chellakkan Selvanesan, Sheelu Varghese, Justyna Andrys-Olek, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Phosphoproteomic dysregulation drives tumor proliferation in Cushing's diseaseDavid T Asuzu, Dustin Mullaney, Debjani Mandal, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomasMaxwell T Laws, Dhruval Bhatt, Debjani Mandal, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry|January 21, 2023
Development of fluorophore labeled or biotinylated anticancer small molecule NSC243928Rahul Prakash, Dustin W Goodlett, Sheelu Varghese, et al.
Cancer Letters|February 22, 2023
Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interactionBenson Chellakkan Selvanesan, Sheelu Varghese, Justyna Andrys-Olek, et al.
Biorxiv : the Preprint Server for Biology|December 31, 2025
Phosphoproteomic dysregulation drives tumor proliferation in Cushing's diseaseDavid T Asuzu, Dustin Mullaney, Debjani Mandal, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomasMaxwell T Laws, Dhruval Bhatt, Debjani Mandal, et al.
Pageof 2